Gagnon Advisors’s GeneDx Holdings Warrant WGSWW Stock Holding History

Gagnon Advisors’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-246,365	Closed	-$56K	–	31
2022 Q3	$56K	Hold	246,365	–	–	0.04%	31
2022 Q2	$80K	Hold	246,365	–	–	0.05%	32
2022 Q1	$170K	Hold	246,365	–	–	0.08%	33
2021 Q4	$241K	Buy	246,365 +122,896	+100%	+$242K	0.1%	33
2021 Q3	$262K	Buy	+123,469	New	+$406K	0.1%	34

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Gagnon Advisors's WGSWW Position: Q4 2022 in Review

Gagnon Advisors sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2022, closing a stake of 246,365 shares — an estimated $56K sold.

Gagnon Advisors first reported a position in WGSWW in Q3 2021 and held it in 5 quarters. The position peaked at $262K in Q3 2021. 26 funds tracked by Wall St. Rank hold WGSWW as of Q4 2022.

Gagnon Advisors reported no remaining GeneDx Holdings Warrant position as of Q4 2022 after selling out during the quarter.
Gagnon Advisors sold 246,365 GeneDx Holdings Warrant shares in Q4 2022, an estimated $56K.
Gagnon Advisors first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 5 quarters.
Gagnon Advisors's GeneDx Holdings Warrant position peaked at $262K in Q3 2021.
26 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2022.

Based on Gagnon Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.